ArticleHealth information science and systems2022
Nationwide hospital admission data statistics and disease-specific 30-day readmission prediction.
Article in Health information science and systems, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Machine Learning-Based Prediction Model for 30-Day Emergency Department Revisits in a Medically Underserved Tertiary Hospital: Formative Retrospective Cohort Study.JMIR formative research · 2026Article
- Diabetes increases the risk of heart failure in myocarditis: a propensity-matched nationwide database analysis.ESC heart failure · 2026Observational
- Beyond the 30-day metric: National trends and predictors of 90-day readmission after coronary artery bypass grafting.American heart journal plus : cardiology research and practice · 2026Article
- Sex Differences in 90-Day Readmission and Mortality Trends in Heart Failure With Preserved Ejection Fraction: Insights From the National Readmissions Database.International journal of heart failure · 2025Article
- Article
- Article
- Sarcopenia as a Robust Predictor of Readmission within 6 Months among Individuals Experiencing Acute Stroke.Annals of geriatric medicine and research · 2024Article
- Impact of time from discharge to readmission on outcomes: an observational study from the US National Readmission Database.BMJ open · 2024Observational
- Development and validation of a diagnostic model to differentiate spinal tuberculosis from pyogenic spondylitis by combining multiple machine learning algorithms.Biomolecules & biomedicine · 2024Article
- Readmission rates and outcomes in adults with and without COVID-19 following inpatient chemotherapy admission: A nationwide analysis.World journal of clinical oncology · 2023Article
- Differences in Hospitalization and Inpatient Death Patterns by Incarceration Status in 31 US Jurisdictions, 2021.Public health reports (Washington, D.C. : 1974)Article
- Machine Learning-Based Prediction of Unplanned Readmission Due to Major Adverse Cardiac Events Among Hospitalized Patients with Blood Cancers.Cancer control : journal of the Moffitt Cancer CenterArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Hospital readmission prediction uses historical patient visit data to train machine learning models to predict risk of patients being readmitted after the discharge. Data used to train models, such as patient demographics, disease types, localized distributions etc., play significant roles in the model performance. To date, many methods exist for hospital readmission prediction, but answers to some important questions still remain open. For example, how will demographics, such as gender, age, geographic, impact on readmission prediction? Do patients suffering from different diseases vary significantly in their readmission rates? What are the nationwide hospital admission data characteristics? and how do hospital speciality, ownership, and locations impact on their readmission rates? In this study, we carry systematic investigations to answer the above questions, and propose a predictive modeling framework to predict disease-specific 30-day hospital readmission. Methods: We first implement statistics analysis by using National Readmission Databases (NRD) with over 15 million hospital visits. After that, we create features and disease-specific readmission datasets. An ensemble learning framework is proposed to conduct hospital readmission prediction and Friedman test and Nemenyi post-hoc test is used to validate our proposed method. Results: Using National Readmission Databases (NRD), with over 15 million hospital visits, as our testbed, we summarize nationwide patient admission data statistics, in related to demographic, disease types, and hospital factors. We use feature engineering to design 526 representative features to model each patient visit. Our studies found that readmission rates vary significantly from diseases to diseases. For six diseases studied in our research, their readmission rates vary from 1.832 (Pneumonia) to 8.761% (Diabetes). Using random sampling and voting approaches, our study shows that soft voting outperforms hard voting on majority results, especially for AUC and balanced accuracy which are the main measures for imbalanced data. Random under sampling using 1.1:1 for negative:positive ratio achieves the best performance for AUC, balanced accuracy, and F1-score. Conclusion: This paper carries out systematic studies to understand US nationwide hospital readmission data statistics, and further designs a machine learning framework for disease-specific 30-day hospital readmission prediction. Our study shows that hospital readmission rates vary significantly with respect to different disease types, gender, age groups, any other factors. Gradient boosting achieves the best performance for disease specific hospital readmission prediction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.